908.5500 -3.70 (-0.41%)
NSE Dec 02, 2025 11:55 AM
Volume: 100.0K
 

908.55
-0.41%
Geojit BNP Paribas
Management remains optimistic about performance in other regulated markets, anticipating stronger revenue growth in FY26 as European partners prepare for product launches. The company also expects these markets to eventually generate...
Strides Pharma has lost -44.44% in the last 1 Year
More from Strides Pharma Science Ltd.
Recommended